For citations:
Popova EV, Melnikov MV, Boyko AN, Paschenkov MB. IMMUNOLOGICAL PRECONDITIONS OF CONVERSION FROM NATALIZUMAB TO FINGOLIMOD. Meditsinskiy sovet = Medical Council. 2017;(1S):80-83. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-80-83